Publication | Closed Access

2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

Cardiovascular EpidemiologyCardiovascular DiseaseNonstatin TherapiesPharmacologyHyperlipidemiaVascular BiologyDyslipidemiaLdl-cholesterol LoweringPublic HealthMedicineAtherosclerosisCardiovascular Disease Risk Assessment